Advertisement
Screener

Immune Design Corp. Research and Development Expense

Immune Design Corp. Research and Development Expense

Immune Design Corp. reported Research and Development Expense of $42.41 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-03-13.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2019-03-13

  • Immune Design Corp. research and development expense for the quarter ending 2018-12-31 was $9.84M, a 15.41% increase year-over-year.
  • Immune Design Corp. research and development expense for the quarter ending 2018-09-30 was $11.27M, a 9.97% increase year-over-year.
  • Immune Design Corp. research and development expense for the quarter ending 2018-06-30 was $11.00M, a 1.26% increase year-over-year.
  • Immune Design Corp. research and development expense for the quarter ending 2018-03-31 was $10.31M, a 26.55% decline year-over-year.
  • Immune Design Corp. research and development expense for fiscal 2018 was $42.41M, a 2.87% decline from fiscal 2017.
  • Immune Design Corp. research and development expense for fiscal 2017 was $43.67M, a 3.24% decline from fiscal 2016.
  • Immune Design Corp. research and development expense for fiscal 2016 was $45.13M, a 36.41% increase from fiscal 2015.
  • Immune Design Corp. research and development expense for fiscal 2015 was $33.09M, a 45.46% increase from fiscal 2014.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2018-12-31$9.84M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$21.10M
derived: sum of 2 quarters · filed 2019-03-13
$32.10M
derived: sum of 3 quarters · filed 2019-03-13
$42.41M
10-K · filed 2019-03-13
2018-09-30$11.27M
10-Q · filed 2018-11-06
$22.27M
derived: sum of 2 quarters · filed 2018-11-06
$32.58M
10-Q · filed 2018-11-06
$41.10M
derived: sum of 4 quarters · filed 2019-03-13
2018-06-30$11.00M
10-Q · filed 2018-08-01
$21.31M
10-Q · filed 2018-08-01
$29.83M
derived: sum of 3 quarters · filed 2019-03-13
$40.08M
derived: sum of 4 quarters · filed 2019-03-13
2018-03-31$10.31M
10-Q · filed 2018-05-03
$18.83M
derived: sum of 2 quarters · filed 2019-03-13
$29.08M
derived: sum of 3 quarters · filed 2019-03-13
$39.94M
derived: sum of 4 quarters · filed 2019-03-13
2017-12-31$8.52M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$18.77M
derived: sum of 2 quarters · filed 2019-03-13
$29.63M
derived: sum of 3 quarters · filed 2019-03-13
$43.67M
10-K · filed 2019-03-13
2017-09-30$10.25M
10-Q · filed 2018-11-06
$21.11M
derived: sum of 2 quarters · filed 2018-11-06
$35.15M
10-Q · filed 2018-11-06
$47.15M
derived: sum of 4 quarters · filed 2019-03-13
2017-06-30$10.86M
10-Q · filed 2018-08-01
$24.90M
10-Q · filed 2018-08-01
$36.91M
derived: sum of 3 quarters · filed 2019-03-13
$48.08M
derived: sum of 4 quarters · filed 2019-03-13
2017-03-31$14.04M
10-Q · filed 2018-05-03
$26.04M
derived: sum of 2 quarters · filed 2019-03-13
$37.22M
derived: sum of 3 quarters · filed 2019-03-13
$48.60M
derived: sum of 4 quarters · filed 2019-03-13
2016-12-31$12.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$23.18M
derived: sum of 2 quarters · filed 2019-03-13
$34.56M
derived: sum of 3 quarters · filed 2019-03-13
$45.13M
10-K · filed 2019-03-13
2016-09-30$11.17M
10-Q · filed 2017-11-01
$22.56M
derived: sum of 2 quarters · filed 2017-11-01
$33.13M
10-Q · filed 2017-11-01
$42.01M
derived: sum of 4 quarters · filed 2018-03-14
2016-06-30$11.39M
10-Q · filed 2017-08-02
$21.96M
10-Q · filed 2017-08-02
$30.83M
derived: sum of 3 quarters · filed 2018-03-14
$39.10M
derived: sum of 4 quarters · filed 2018-03-14
2016-03-31$10.57M
10-Q · filed 2017-05-04
$19.45M
derived: sum of 2 quarters · filed 2018-03-14
$27.71M
derived: sum of 3 quarters · filed 2018-03-14
$36.19M
derived: sum of 4 quarters · filed 2018-03-14
2015-12-31$8.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14
$17.14M
derived: sum of 2 quarters · filed 2018-03-14
$25.62M
derived: sum of 3 quarters · filed 2018-03-14
$33.09M
10-K · filed 2018-03-14
2015-09-30$8.26M
10-Q · filed 2016-11-09
$16.75M
derived: sum of 2 quarters · filed 2016-11-09
$24.21M
10-Q · filed 2016-11-09
$33.01M
derived: sum of 4 quarters · filed 2017-03-07
2015-06-30$8.48M
10-Q · filed 2016-08-09
$15.95M
10-Q · filed 2016-08-09
$24.74M
derived: sum of 3 quarters · filed 2017-03-07
$30.73M
derived: sum of 4 quarters · filed 2017-03-07
2015-03-31$7.46M
10-Q · filed 2016-05-10
$16.26M
derived: sum of 2 quarters · filed 2017-03-07
$22.25M
derived: sum of 3 quarters · filed 2017-03-07
$26.13M
derived: sum of 4 quarters · filed 2017-03-07
2014-12-31$8.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-07
$14.79M
derived: sum of 2 quarters · filed 2017-03-07
$18.67M
derived: sum of 3 quarters · filed 2017-03-07
$22.75M
10-K · filed 2017-03-07
2014-09-30$5.99M
10-Q · filed 2015-11-12
$9.87M
derived: sum of 2 quarters · filed 2015-11-12
$13.95M
10-Q · filed 2015-11-12
$16.68M
derived: sum of 4 quarters · filed 2016-03-15
2014-06-30$3.88M
10-Q · filed 2015-08-12
$7.96M
10-Q · filed 2015-08-12
$10.70M
derived: sum of 3 quarters · filed 2016-03-15
$13.62M
derived: sum of 4 quarters · filed 2016-03-15
2014-03-31$4.08M
10-Q · filed 2015-05-14
$6.81M
derived: sum of 2 quarters · filed 2016-03-15
$9.73M
derived: sum of 3 quarters · filed 2016-03-15
$13.09M
derived: sum of 4 quarters · filed 2016-03-15
2013-12-31$2.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15
$5.66M
derived: sum of 2 quarters · filed 2016-03-15
$9.01M
derived: sum of 3 quarters · filed 2016-03-15
$11.55M
10-K · filed 2016-03-15
2013-09-30$2.92M
10-Q · filed 2014-11-13
$6.28M
derived: sum of 2 quarters · filed 2014-11-13
$8.82M
10-Q · filed 2014-11-13
2013-06-30$3.36M
10-Q · filed 2014-09-08
$5.90M
10-Q · filed 2014-09-08
2012-12-31$8.60M
10-K · filed 2015-03-31